Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Cybin
Recent news which mentions Cybin
Cybin: Positive Data Announced From Innovative Drug Trial
March 02, 2023
Tags
Market News
Benzinga
Biotech
From
Benzinga
Cybin: Psychedelic Based BioPharma Company To Announce Much Anticipated Updates For Its Ongoing Clinical Trials
February 27, 2023
Tags
Benzinga
Market News
Interview
From
Benzinga
Cybin Approved For First In-Human Dosing Of DMT Molecule CYB004, Milestone For Anxiety Disorder Treatment
February 01, 2023
Tickers
CYBN
DMT
Tags
Doug Drysdale
Markets
DMT
From
Benzinga
Cybin Acquires Exclusive License To Mindset Pharma's Tryptamine Compounds Family
September 27, 2022
Tickers
CYBN
MSSTF
Tags
News
Cannabis
MSSTF
From
Benzinga
BREAKING: Cybin And Clinilabs Receive DEA License For First-In-Human Clinical Trial Of Psilocybin To Treat Depression
August 17, 2022
Tickers
CYBN
DEA
MDD
Tags
Psilocybin
Psychedelics
Biotech
From
Benzinga
This Psychedelics Company Is Setting Up An Equity Program For Up To $35M In Shares
August 09, 2022
Tickers
CYBN
SEC
Tags
Benzinga
Cantor Fitzgerald
Offerings
From
Benzinga
How Does Ketamine Affect The Brain Over Time?
June 25, 2022
Tags
Psychedelics
Markets
Kernel
From
Benzinga
Cybin Presents "Why Cybin Is Investing So Heavily On Developing Novel Psychedelic Molecules" At The Psychedelic Capital Conference
April 25, 2022
Tickers
CYBN
Tags
Market News
CYBN
Penny Stocks
From
Benzinga
Cybin's Major Depressive Disorder Treatment Trials Continue With Clinilabs Drug Development Corp
April 22, 2022
Tickers
CYBN
Tags
Markets
Doug Drysdale
News
From
Benzinga
Cybin's CYB0004 Shows Positive Preclinical Results Over Traditional Psychedelics
April 13, 2022
Tickers
CYBN
Tags
Benzinga
Psychedelics
Markets
From
Benzinga
WIPO Publishes Cybin's Patent Application For Inhaled Psychedelics Therapies
April 08, 2022
Tickers
CYBN
Tags
Penny Stocks
CYBN
Market News
From
Benzinga
A Builder From The Ground Up, Doug Drysdale, CEO of Cybin: Meet Our Speakers
April 06, 2022
Tickers
AGN
CYBN
PTX
Tags
Psychedelics
Small Business
Success Stories
From
Benzinga
Cybin Begins Study Using Kernel Flow Headsets To Measure Ketamine's Effects On The Brain
March 31, 2022
Tickers
CYBN
Tags
Benzinga
Psychedelics
Kernel
From
Benzinga
Cybin Completes In Vivo Preclinical Studies For Major Depressive Disorder
March 29, 2022
Tickers
CYBN
Tags
Psychedelics
Markets
Benzinga
From
Benzinga
Five Companies Developing Second Generation Psychedelics For Mental Health
March 24, 2022
Tickers
CYBN
ENVB
FTRP
MNMD
Tags
MSSTF
MindMed
Field Trip
From
Benzinga
Cybin Reports Q2 Financial Results And Latest News, Including FDA & DEA Research Approvals
November 15, 2021
Tickers
CYBN
Tags
Benzinga
Doug Drysdale
Earnings
From
Benzinga
Cybin Announces Positive Data Showing Effectiveness of Psilocybin To Treat Depression
November 08, 2021
Tickers
CYBN
Tags
Psychedelics Therapy
Markets
Doug Drysdale
From
Benzinga
Cybin: FDA Authorizes Feasibility Study To Measure Ketamine's Effect On Cerebral Cortex
October 27, 2021
Tickers
CYBN
Tags
Benzinga
Biotech
Cybin
From
Benzinga
Cybin Inc. (NEO: CYBN) (NYSE: CYBN) Files Two International Patent Applications In Support Of The Company's Research Phase Programs
August 19, 2021
Tickers
CYBN
Tags
Global
Penny Stocks
General
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit